Andrew Dakos - 30 Dec 2025 Form 4 Insider Report for SPECIAL OPPORTUNITIES FUND, INC. (SPE)

Signature
/s/ Stephanie Darling, Power of Attorney for Andrew Dakos
Issuer symbol
SPE
Transactions as of
30 Dec 2025
Net transactions value
-$60,065
Form type
4
Filing time
31 Dec 2025, 17:01:47 UTC
Previous filing
12 Dec 2025
Next filing
13 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dakos Andrew President, Director PARK 80 WEST-PLAZA TWO, 250 PEHLE AVE., SUITE 708, SADDLE BROOK /s/ Stephanie Darling, Power of Attorney for Andrew Dakos 31 Dec 2025 0001341021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPE Common Stock Sale $60,065 -4,098 -40% $14.66 6,064 30 Dec 2025 Direct F1
holding SPE Common Stock 4,880 30 Dec 2025 By Spouse F2
holding SPE Common Stock 782 30 Dec 2025 By Minor Children F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.61 to $14.68, inclusive. The reporting person hereby undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F2 The Reporting Person disclaims beneficial ownership of the securities owned by his spouse and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
F3 The Reporting Person disclaims beneficial ownership of the securities owned by his minor children and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.